These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 1370203

  • 1. Primary myelodysplastic syndromes: diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies.
    Mangi MH, Mufti GJ.
    Blood; 1992 Jan 01; 79(1):198-205. PubMed ID: 1370203
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bone marrow biopsy in myelodysplastic syndromes: morphological characteristics and contribution to the study of prognostic factors.
    Ríos A, Cañizo MC, Sanz MA, Vallespí T, Sanz G, Torrabadella M, Gomis F, Ruiz C, San Miguel JF.
    Br J Haematol; 1990 May 01; 75(1):26-33. PubMed ID: 2375920
    [Abstract] [Full Text] [Related]

  • 6. CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes.
    Soligo DA, Oriani A, Annaloro C, Cortelezzi A, Calori R, Pozzoli E, Nosella D, Orazi A, Deliliers GL.
    Am J Hematol; 1994 May 01; 46(1):9-17. PubMed ID: 7514357
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
    Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B, De Wolf-Peeters C, Van den Berghe H, Verwilghen RL.
    Br J Haematol; 1985 May 01; 60(1):19-32. PubMed ID: 3859319
    [Abstract] [Full Text] [Related]

  • 9. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y.
    Oncologist; 1996 May 01; 1(4):284-287. PubMed ID: 10388004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Deficiency of pluripotent hemopoietic progenitor cells in myelodysplastic syndromes.
    Geissler K, Hinterberger W, Jäger U, Bettelheim P, Neumann E, Haas O, Ambros P, Chott A, Radaszkiewicz T, Lechner K.
    Blut; 1988 Jul 01; 57(1):45-9. PubMed ID: 3390617
    [Abstract] [Full Text] [Related]

  • 16. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
    Foucar K, Langdon RM, Armitage JO, Olson DB, Carroll TJ.
    Cancer; 1985 Aug 01; 56(3):553-61. PubMed ID: 3891071
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of bone marrow study in diagnosis and prognosis of myelodysplastic syndrome.
    Saad ST, Vassallo J, Arruda VA, Lorand-Metze I.
    Pathologica; 1994 Feb 01; 86(1):47-51. PubMed ID: 8072801
    [Abstract] [Full Text] [Related]

  • 19. [Study on pathophysiology of the myelodysplastic syndromes (MDS)--pattern of dysmegakaryopoiesis related to leukemic transformation].
    Tomonaga M, Jinnai I, Kuriyama K, Nonaka H, Amenomori T, Matsuo T, Yoshida Y, Sasagawa I, Sadamori N, Ichimaru M.
    Rinsho Ketsueki; 1989 Oct 01; 30(10):1788-99. PubMed ID: 2593245
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.